Discuss cutting-edge topics with CGT experts during ASGCT's Insights Week! Choose from five daily sessions between Oct. 16-20
As part of ASGCT’s efforts to expand its mission outside of the U.S., we're now offering all the benefits of membership at reduced rates to individuals living in countries with low- and middle-income economies as classified by the World Bank.
Members residing in countries designated as upper-middle income economies, such as Brazil, South Africa, and many others, will be eligible for a 50 percent reduction on membership dues. Members residing in countries designated as lower middle-income economies, including Ukraine, India, and many others, will be eligible for a 75 percent reduction on membership dues. Members residing in countries designated as low-income economies will be eligible for a 90 percent reduction on membership dues.
Membership Type
Upper-Middle Income
Lower-Middle Income
Low-Income
Associate Member
$37.50
$18.75
$7.50
Transitional Member
$55
$27.50
$11
Member
$110
$22
If you have any questions, please contact info@asgct.org. Individuals who receive these reduced rates will only be eligible for the online version of ASGCT's journal, Molecular Therapy.
Become a Member
Watch on demand through Oct. 23!
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico